Sign in
Home
About Us
Contact Us
Privacy Policy
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Australian Biotech Company News
Home
About Us
Contact Us
Privacy Policy
Home
Tags
CRISPR
Tag: CRISPR
Biotechnology
CRISPR Screen Reveals Control Knob for Regulatory T Cells
BioChannel
-
July 8, 2020
Biotechnology
CRISPR Tool, in “CARPID Diem” Spirit, Detects RNA-Protein Interactions in Living...
BioChannel
-
July 1, 2020
Biotechnology
COVID-19 Mouse CRISPR Engineered to Recapitulate Human COVID-19
BioChannel
-
May 27, 2020
Biotechnology
CRISPR-Based In Vivo Genome Editing and Base Editing
BioChannel
-
May 6, 2020
Biotechnology
10 Unusual Applications of CRISPR Gene Editing
BioChannel
-
March 30, 2020
Biotechnology
Cellectis’ New Patent Supports CRISPR-Based T-Cell Immunotherapies
BioChannel
-
March 20, 2020
Biotechnology
Could a CRISPR Therapeutic Cure Sickle-Cell Disease?
BioChannel
-
March 1, 2020
Biotechnology
Base Editing Promise in Treating a Mouse Model of Progeria
BioChannel
-
February 14, 2020
Biotechnology
Beam Therapeutics, Base Editing Drug Developer, Raises $180M in IPO
BioChannel
-
February 6, 2020
Biotechnology
Mammoth Pursues Coronavirus Partnership as It Grows CRISPR Ambitions
BioChannel
-
January 30, 2020
1
2
3
4
Page 1 of 4
Stay connected
50,915
Followers
Follow
14,700
Subscribers
Subscribe
Recent posts
Life in the Time of Coronavirus
BioChannel
-
July 10, 2020
Study pinpoints brain cells that trigger sugar cravings and consumption
BioChannel
-
July 10, 2020
Life Sciences Fund Launches with €76M to Invest in Nordic Biotech
BioChannel
-
July 10, 2020
Random article
Life in the Time of Coronavirus
Study pinpoints brain cells that trigger sugar cravings and consumption
Life Sciences Fund Launches with €76M to Invest in Nordic Biotech
VarmX bags €32m in Series B round – European Biotechnology News
Edit with Live CSS